Target Name: FATE1
NCBI ID: G89885
Review Report on FATE1 Target / Biomarker Content of Review Report on FATE1 Target / Biomarker
FATE1
Other Name(s): CT43 | cancer/testis antigen 43 | Fetal and adult testis-expressed transcript protein | Cancer/testis antigen 43 | BJ-HCC-2 antigen | fetal and adult testis expressed 1 | FATE1_HUMAN | FATE | Tumor antigen BJ-HCC-2 | tumor antigen BJ-HCC-2 | Fetal and adult testis expressed 1 | Protein BJ-HCC-2

FATE1: A Protein Involved in Cell Division, Growth and Metabolism

FATE1 (Fate Translocation Protein 1) is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell division and has been implicated in a number of diseases, including cancer. In recent years, researchers have been interested in studying FATE1 as a potential drug target or biomarker.

FATE1 is a transmembrane protein that is involved in the regulation of cell division. It is a key regulator of the G1/S transition, which is the stage of cell division where the cell prepares for cell division by duplicating its DNA. FATE1 helps to ensure that the DNA double is accurately duplicated and that the cell enters the G2 phase, which is when the cell prepares for cell division by duplicating its chromosomes.

In addition to its role in cell division, FATE1 has also been shown to play a role in the regulation of cell growth and the development of cancer. Studies have shown that FATE1 is highly expressed in a variety of cancer types, including breast, ovarian, and colorectal cancers. It is also has been shown to be involved in the regulation of cell survival and the ability of cancer cells to evade apoptosis, which is the process by which a cell is programmed to die.

FATE1 has also been shown to be involved in the regulation of inflammation and immune response. Studies have shown that FATE1 is highly expressed in immune cells and that it is involved in the regulation of inflammation. This suggests that FATE1 may be a potential drug target or biomarker for a variety of inflammatory and cancer-related diseases.

FATE1 has also been shown to play a role in the regulation of metabolism and the ability of cells to access energy. Studies have shown that FATE1 is involved in the regulation of glucose metabolism and that it helps to ensure that cells have access to the energy they need to divide and grow.

In conclusion, FATE1 is a protein that has been shown to play a role in a variety of processes in the body, including cell division, growth, and metabolism. As such, it is a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of FATE1 in these processes and to determine its potential as a drug or biomarker.

Protein Name: Fetal And Adult Testis Expressed 1

Functions: Involved in the regulation of endoplasmic reticulum (ER)-mitochondria coupling. Negatively regulates the ER-mitochondria distance and Ca(2+) transfer from ER to mitochondria possibly implicating it in the regulation of apoptosis (PubMed:27402544). May collaborate with RNF183 to restrain BIK protein levels thus regulating apoptotic signaling (PubMed:26567849)

The "FATE1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FATE1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Fatty Acid Binding Protein | Fatty acid desaturase | FAU | FAUP1 | FAUP4 | FAXC | FAXDC2 | FBF1 | FBH1 | FBL | FBLIM1 | FBLL1 | FBLN1 | FBLN2 | FBLN5 | FBLN7 | FBN1 | FBN2 | FBN3 | FBP1 | FBP2 | FBRS | FBRSL1 | FBXL12 | FBXL13 | FBXL14 | FBXL15 | FBXL16 | FBXL17 | FBXL18 | FBXL19 | FBXL19-AS1 | FBXL2 | FBXL20 | FBXL21P | FBXL22 | FBXL3 | FBXL4 | FBXL5 | FBXL6 | FBXL7 | FBXL8 | FBXL9P | FBXO10 | FBXO11 | FBXO15 | FBXO16 | FBXO17 | FBXO2 | FBXO21 | FBXO22 | FBXO24 | FBXO25 | FBXO27 | FBXO28 | FBXO3 | FBXO30 | FBXO31 | FBXO32 | FBXO33 | FBXO34 | FBXO36 | FBXO38 | FBXO39 | FBXO4 | FBXO40 | FBXO41 | FBXO42 | FBXO43 | FBXO44 | FBXO45 | FBXO46 | FBXO47 | FBXO48 | FBXO5 | FBXO6 | FBXO7 | FBXO8 | FBXO9 | FBXW10 | FBXW10B | FBXW11 | FBXW12 | FBXW2 | FBXW4 | FBXW4P1 | FBXW5 | FBXW7 | FBXW7-AS1 | FBXW8 | FBXW9 | Fc-gamma Receptor (FCGR) | FCAMR | FCAR | FCER1A | FCER1G | FCER2 | FCF1 | FCF1P11 | FCF1P2